{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:56:36Z","timestamp":1794873396911,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The neurochemical alterations in cerebrospinal fluid (CSF) associated with the typical symptomatology in idiopathic normal pressure hydrocephalus (iNPH) and their association with outcome after shunt surgery are unsettled.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>To explore associations between concentrations of CSF biomarkers reflecting amyloid- and tau pathology, neuronal degeneration as well as astrocytic activation and the characteristic symptomatology in iNPH and to examine whether these biomarkers can predict the postoperative outcome in all patients and in patients without evidence of Alzheimer\u2019s disease (AD) pathology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This explorative study included 81 patients diagnosed with iNPH at the Hydrocephalus research unit, Sahlgrenska. Symptoms were assessed using the iNPH-scale and standardized clinical tests measuring gait, balance, cognition and urinary incontinence before and median 8 months after shunt surgery. Pre-operative lumbar CSF concentrations of A\u03b238, A\u03b240, A\u03b242, ratio A\u03b242\/A\u03b240, sAPP\u03b1, sAPP\u03b2, T-tau, P-tau, MCP-1, and NFL were analyzed. A low A\u03b242\/A\u03b240 ratio defined patients with AD pathology. Correlation and regression analyses between biomarker concentrations and clinical symptoms at baseline as well as postoperative change in symptoms after surgery, were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Higher NFL correlated with more pronounced impairment in all clinical tests, i.e. included measures of gait, balance, cognition and urinary incontinence (r<jats:sub>p<\/jats:sub>=0.25\u20130.46, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Higher T-tau and P-tau correlated with poorer performance in cognitive tests (r<jats:sub>p<\/jats:sub>=0.26\u20130.39, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). No biomarker could differentiate between improved and unimproved patients in the whole sample or in AD-pathology negative patients. Low ratio A\u03b242\/A\u03b240 lacked predictive value. A higher preoperative P-tau was weakly correlated with less pronounced overall clinical improvement (r<jats:sub>p<\/jats:sub> = -0.238, <jats:italic>p<\/jats:italic>\u2009=\u20090.036).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Axonal degeneration, as indicated by elevated NFL, is probably involved in the generation of the full iNPH tetrade of symptoms and tau pathology more specifically with iNPH cognitive impairment. No CSF biomarker could identify shunt responders. CSF evidence of Alzheimer pathology should not be used to exclude patients from shunt surgery.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12987-025-00661-w","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:23:10Z","timestamp":1747642990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Idiopathic normal pressure hydrocephalus: associations between CSF biomarkers, clinical symptoms, and outcome after shunt surgery"],"prefix":"10.1186","volume":"22","author":[{"given":"Majd","family":"Saadaldeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jeppsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Wikkels\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Tullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"661_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJM196507152730301","volume":"273","author":"RD Adams","year":"1965","unstructured":"Adams RD, et al. Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure. A treatable syndrom. N Engl J Med. 1965;273:117\u201326.","journal-title":"N Engl J Med"},{"issue":"16","key":"661_CR2","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000000342","volume":"82","author":"D Jaraj","year":"2014","unstructured":"Jaraj D, et al. Prevalence of idiopathic normal-pressure hydrocephalus. Neurology. 2014;82(16):1449\u201354.","journal-title":"Neurology"},{"issue":"2","key":"661_CR3","doi-asserted-by":"publisher","first-page":"e208037","DOI":"10.1212\/WNL.0000000000208037","volume":"102","author":"C Constantinescu","year":"2024","unstructured":"Constantinescu C, et al. Prevalence of possible idiopathic normal pressure hydrocephalus in Sweden: A Population-Based MRI study in 791 70-Year-Old participants. Neurology. 2024;102(2):e208037.","journal-title":"Neurology"},{"key":"661_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/3-211-32318-X_48","volume":"95","author":"A Marmarou","year":"2005","unstructured":"Marmarou A, et al. Guidelines for management of idiopathic normal pressure hydrocephalus: progress to date. Acta Neurochir Suppl. 2005;95:237\u201340.","journal-title":"Acta Neurochir Suppl"},{"issue":"3","key":"661_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0404.2012.01676.x","volume":"126","author":"P Klinge","year":"2012","unstructured":"Klinge P, Hellstrom P, Tans J, Wikkelso C. One-year outcome in the European multicentre study on iNPH. Acta Neurol Scand. 2012;126(3):145\u201353.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"661_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1743-8454-7-18","volume":"7","author":"M Hashimoto","year":"2010","unstructured":"Hashimoto M, Ishikawa M, Mori E, Kuwana N. Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res. 2010;7(1):18.","journal-title":"Cerebrospinal Fluid Res"},{"issue":"11","key":"661_CR7","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1136\/jnnp.2007.123620","volume":"79","author":"S Pujari","year":"2008","unstructured":"Pujari S, et al. Normal pressure hydrocephalus: long-term outcome after shunt surgery. J Neurol Neurosurg Psychiatry. 2008;79(11):1282\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"661_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/mdc3.12335","volume":"3","author":"R Shaw","year":"2016","unstructured":"Shaw R, Mahant N, Jacobson E, Owler B. A review of clinical outcomes for gait and other variables in the surgical treatment of idiopathic normal pressure hydrocephalus. Mov Disord Clin Pract. 2016;3(4):331\u201341.","journal-title":"Mov Disord Clin Pract"},{"issue":"5","key":"661_CR9","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3171\/2022.2.JNS212063","volume":"137","author":"N Sundstrom","year":"2022","unstructured":"Sundstrom N, et al. The demography of idiopathic normal pressure hydrocephalus: data on 3000 consecutive, surgically treated patients and a systematic review of the literature. J Neurosurg. 2022;137(5):1310\u201320.","journal-title":"J Neurosurg"},{"issue":"4","key":"661_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-0404.2012.01677.x","volume":"126","author":"P Hellstrom","year":"2012","unstructured":"Hellstrom P, Klinge P, Tans J, Wikkelso C. A new scale for assessment of severity and outcome in iNPH. Acta Neurol Scand. 2012;126(4):229\u201337.","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"661_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1212\/WNL.0000000000003583","volume":"88","author":"H Israelsson","year":"2017","unstructured":"Israelsson H, et al. Vascular risk factors in INPH: A prospective case-control study (the INPH-CRasH study). Neurology. 2017;88(6):577\u201385.","journal-title":"Neurology"},{"issue":"11","key":"661_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2176\/nmc.52.775","volume":"52","author":"E Mori","year":"2012","unstructured":"Mori E, et al. Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. Neurol Med Chir (Tokyo). 2012;52(11):775\u2013809.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"4","key":"661_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1001\/archneur.1974.00490400076009","volume":"31","author":"MP Earnest","year":"1974","unstructured":"Earnest MP, Fahn S, Karp JH, Rowland LP. Normal pressure hydrocephalus and hypertensive cerebrovascular disease. Arch Neurol. 1974;31(4):262\u20136.","journal-title":"Arch Neurol"},{"issue":"3","key":"661_CR14","doi-asserted-by":"publisher","first-page":"e13720","DOI":"10.15252\/emmm.202013720","volume":"13","author":"V Leinonen","year":"2021","unstructured":"Leinonen V, Kuulasmaa T, Hiltunen M. iNPH-the mystery resolving. EMBO Mol Med. 2021;13(3):e13720.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"661_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1365-2990.2011.01195.x","volume":"38","author":"V Leinonen","year":"2012","unstructured":"Leinonen V, et al. Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature. Neuropathol Appl Neurobiol. 2012;38(1):72\u201386.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"661_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-8118-9-7","volume":"9","author":"S Patel","year":"2012","unstructured":"Patel S, et al. Phosphorylated tau\/amyloid beta 1\u201342 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2012;9(1):7.","journal-title":"Fluids Barriers CNS"},{"issue":"1\u20132","key":"661_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jns.2015.06.029","volume":"356","author":"K Hiraoka","year":"2015","unstructured":"Hiraoka K, et al. Amyloid deposits and response to shunt surgery in idiopathic normal-pressure hydrocephalus. J Neurol Sci. 2015;356(1\u20132):124\u20138.","journal-title":"J Neurol Sci"},{"issue":"10","key":"661_CR18","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/jnnp-2019-320826","volume":"90","author":"A Jeppsson","year":"2019","unstructured":"Jeppsson A, et al. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics. J Neurol Neurosurg Psychiatry. 2019;90(10):1117\u201323.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"661_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12987-022-00309-z","volume":"19","author":"H Lukkarinen","year":"2022","unstructured":"Lukkarinen H, et al. Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients. Fluids Barriers CNS. 2022;19(1):11.","journal-title":"Fluids Barriers CNS"},{"key":"661_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jns.2016.08.040","volume":"369","author":"H Kazui","year":"2016","unstructured":"Kazui H, et al. Association between high biomarker probability of Alzheimer\u2019s disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus. J Neurol Sci. 2016;369:236\u201341.","journal-title":"J Neurol Sci"},{"issue":"1","key":"661_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12987-022-00306-2","volume":"19","author":"M Braun","year":"2022","unstructured":"Braun M, et al. Higher levels of neurofilament light chain and total Tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus. Fluids Barriers CNS. 2022;19(1):15.","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"661_CR22","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/neurosurgery\/57.3.N4","volume":"57","author":"N Relkin","year":"2005","unstructured":"Relkin N, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57(3):S4\u201316. discussion ii-v.","journal-title":"Neurosurgery"},{"key":"661_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/00006231-198304020-00005","volume":"4","author":"C Wikkelso","year":"1983","unstructured":"Wikkelso C, Andersson H, Lindberg S, Blomstrand C. Shuntography: A radionuclide scanning method for evaluation of cerebrospinal fluid shunt patency. Nucl Med Commun. 1983;4:88\u201393.","journal-title":"Nucl Med Commun"},{"issue":"4","key":"661_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1212\/WNL.50.4.1122","volume":"50","author":"M Tullberg","year":"1998","unstructured":"Tullberg M, et al. CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology. 1998;50(4):1122\u20137.","journal-title":"Neurology"},{"issue":"5","key":"661_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1600-0404.2004.00325.x","volume":"110","author":"M Tullberg","year":"2004","unstructured":"Tullberg M, et al. Impaired wakefulness is associated with reduced anterior cingulate CBF in patients with normal pressure hydrocephalus. Acta Neurol Scand. 2004;110(5):322\u201330.","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"661_CR26","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1007\/s00415-024-12248-w","volume":"271","author":"K Andren","year":"2024","unstructured":"Andren K, et al. Symptoms and signs did not predict outcome after surgery: a prospective study of 143 patients with idiopathic normal pressure hydrocephalus. J Neurol. 2024;271(6):3215\u201326.","journal-title":"J Neurol"},{"key":"661_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1600-0447.1993.tb05612.x","volume":"373","author":"G Lindqvist","year":"1993","unstructured":"Lindqvist G, et al. Normal pressure hydrocephalus: psychiatric findings before and after shunt operation classified in a new diagnostic system for organic psychiatry. Acta Psychiatr Scand Suppl. 1993;373:18\u201332.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"661_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jns.2018.05.022","volume":"391","author":"S Agerskov","year":"2018","unstructured":"Agerskov S, et al. The phenotype of idiopathic normal pressure hydrocephalus-a single center study of 429 patients. J Neurol Sci. 2018;391:54\u201360.","journal-title":"J Neurol Sci"},{"issue":"8","key":"661_CR29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","volume":"65","author":"H Zetterberg","year":"2008","unstructured":"Zetterberg H, et al. Elevated cerebrospinal fluid BACE1 activity in incipient alzheimer disease. Arch Neurol. 2008;65(8):1102\u20137.","journal-title":"Arch Neurol"},{"key":"661_CR30","doi-asserted-by":"crossref","unstructured":"Gaetani L et al. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Alzheimer\u2019s Res Therapy, 2018. 10(1).","DOI":"10.1186\/s13195-018-0339-1"},{"issue":"3","key":"661_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/acn3.274","volume":"3","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, et al. CSF Abeta42\/Abeta40 and Abeta42\/Abeta38 ratios: better diagnostic markers of alzheimer disease. Ann Clin Transl Neurol. 2016;3(3):154\u201365.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"661_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12987-023-00475-8","volume":"20","author":"R Gronning","year":"2023","unstructured":"Gronning R, et al. Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2023;20(1):77.","journal-title":"Fluids Barriers CNS"},{"key":"661_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1743-8454-5-9","volume":"5","author":"M Tullberg","year":"2008","unstructured":"Tullberg M, et al. Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus. Cerebrospinal Fluid Res. 2008;5:9.","journal-title":"Cerebrospinal Fluid Res"},{"issue":"2","key":"661_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1440-1819.2000.00658.x","volume":"54","author":"T Kudo","year":"2000","unstructured":"Kudo T, et al. Tau protein is a potential biological marker for normal pressure hydrocephalus. Psychiatry Clin Neurosci. 2000;54(2):199\u2013202.","journal-title":"Psychiatry Clin Neurosci"},{"key":"661_CR35","doi-asserted-by":"publisher","first-page":"120014","DOI":"10.1016\/j.cca.2024.120014","volume":"565","author":"G Musso","year":"2025","unstructured":"Musso G, et al. Blood biomarkers for Alzheimer\u2019s disease with the lumipulse automated platform: Age-effect and clinical value interpretation. Clin Chim Acta. 2025;565:120014.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"661_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1212\/WNL.0b013e3182477eed","volume":"78","author":"N Mattsson","year":"2012","unstructured":"Mattsson N, et al. Age and diagnostic performance of alzheimer disease CSF biomarkers. Neurology. 2012;78(7):468\u201376.","journal-title":"Neurology"},{"issue":"1\u20132","key":"661_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jns.2015.07.001","volume":"357","author":"M Nakajima","year":"2015","unstructured":"Nakajima M, et al. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus. J Neurol Sci. 2015;357(1\u20132):88\u201395.","journal-title":"J Neurol Sci"},{"issue":"8","key":"661_CR38","doi-asserted-by":"publisher","first-page":"e0182288","DOI":"10.1371\/journal.pone.0182288","volume":"12","author":"S Yasar","year":"2017","unstructured":"Yasar S, et al. Alzheimer\u2019s disease pathology and shunt surgery outcome in normal pressure hydrocephalus. PLoS ONE. 2017;12(8):e0182288.","journal-title":"PLoS ONE"},{"issue":"1","key":"661_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/cjn.2017.251","volume":"45","author":"T Pfanner","year":"2018","unstructured":"Pfanner T, Henri-Bhargava A, Borchert S. Cerebrospinal fluid biomarkers as predictors of shunt response in idiopathic normal pressure hydrocephalus: A systematic review. Can J Neurol Sci. 2018;45(1):3\u201310.","journal-title":"Can J Neurol Sci"},{"key":"661_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2018.01.017","volume":"387","author":"YJ Hong","year":"2018","unstructured":"Hong YJ, et al. Preoperative biomarkers in patients with idiopathic normal pressure hydrocephalus showing a favorable shunt surgery outcome. J Neurol Sci. 2018;387:21\u20136.","journal-title":"J Neurol Sci"},{"issue":"2","key":"661_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/jnnp.2006.095117","volume":"78","author":"R Bech-Azeddine","year":"2007","unstructured":"Bech-Azeddine R, et al. Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting. J Neurol Neurosurg Psychiatry. 2007;78(2):157\u201361.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"661_CR42","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/jnnp-2012-303314","volume":"84","author":"C Wikkelso","year":"2013","unstructured":"Wikkelso C, Hellstrom P, Klinge PM, Tans JT. The European iNPH multicentre study on the predictive values of resistance to CSF outflow and the CSF tap test in patients with idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 2013;84(5):562\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00661-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00661-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00661-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:03:40Z","timestamp":1747645420000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-025-00661-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["661"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00661-w","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Regional Ethical Review Board in Gothenburg (DNR 020\u2009\u2212\u200907). Written informed consent to inclusion in the study was given by all patients or their next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}